NeuroPace, Inc.
NPCE
$14.09
-$0.03-0.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 26.59M | 27.35M | 23.52M | 22.52M | 21.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.59M | 27.35M | 23.52M | 22.52M | 21.47M |
| Cost of Revenue | 6.01M | 6.19M | 5.39M | 5.18M | 5.28M |
| Gross Profit | 20.58M | 21.17M | 18.13M | 17.34M | 16.19M |
| SG&A Expenses | 15.32M | 17.19M | 18.11M | 15.05M | 13.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.36M | 29.95M | 30.34M | 27.67M | 25.12M |
| Operating Income | -1.77M | -2.60M | -6.82M | -5.15M | -3.65M |
| Income Before Tax | -2.73M | -3.50M | -8.65M | -6.59M | -5.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.73M | -3.50M | -8.65M | -6.59M | -5.25M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.73M | -3.50M | -8.65M | -6.59M | -5.25M |
| EBIT | -1.77M | -2.60M | -6.82M | -5.15M | -3.65M |
| EBITDA | -1.69M | -2.55M | -6.77M | -5.10M | -3.61M |
| EPS Basic | -0.08 | -0.11 | -0.26 | -0.21 | -0.18 |
| Normalized Basic EPS | -0.05 | -0.07 | -0.16 | -0.13 | -0.11 |
| EPS Diluted | -0.08 | -0.11 | -0.26 | -0.21 | -0.18 |
| Normalized Diluted EPS | -0.05 | -0.07 | -0.16 | -0.13 | -0.11 |
| Average Basic Shares Outstanding | 33.39M | 33.13M | 32.86M | 31.48M | 29.91M |
| Average Diluted Shares Outstanding | 33.39M | 33.13M | 32.86M | 31.48M | 29.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |